Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trialFrançois-Xavier Lescure, Stéphane Doucet, Genming Shi et al.|The Lancet Respiratory Medicine|2021Cited by 248
Safety and Immunovirologic Outcomes with Maraviroc Combination Regimens in Patients with a History of Past Treatment Failures and Virologic Resistance in Brazil: An Open-Label, Multicenter Phase 3b StudyJuvêncio José Duailibe Furtado, Lourenia M. Cassoli, José Valdez Madruga et al.|AIDS Research and Human Retroviruses|2013Cited by 5